Pioneer Group

#AbbVie #Funding #Pioneer Group

They’ve got a Golden Ticket: Alceus Bio wins 2025 initiative 

Biotechnology company Alceus Bio has been awarded Pioneer Group and AbbVie’s 2025 Golden Ticket.  The company, a developer of synthetic chimeric antigen receptor T-lymphocyte therapies for solid malignancies, was chosen as the winner after an extensive selection process.  The Golden Ticket provides a significant package of… Read More

#News

#Artificial intelligence (AI) #AstraZeneca #Innovate UK #Pioneer Group #The Medical Research Council

Industry and academic partners promote AI innovation

Pioneer Group, Innovate UK, The Medical Research Council (MRC) and AstraZeneca have joined forces to deliver the AI in Health Accelerator 2024/2025 Programme.  The Accelerator is designed to help entrepreneurs confidently market their AI-driven healthcare solutions and accelerate novel technology development time to market.   The partners will collaborate across all… Read More

#Business & Investment #News

#Biotechnology #Cardiometabolic diseases #Diabetes #Funding #Novo Nordisk #Pioneer Group

UK biotech Golden Ticket programme open for applications

Pioneer Group has teamed up with global healthcare company Novo Nordisk to launch a ‘Golden Ticket’ programme designed to help accelerate innovations in cardiometabolic health. The Golden Ticket programme is aimed at early-stage biotech companies focused on novel drug targets and transformational medicines in cardiometabolic diseases, rare blood and rare… Read More

#Business & Investment #News